Private Equity & Investment Funds

Translate this page Share this page Print this page


Employee Benefits &
Executive Compensation
Energy & Natural Resources
Healthcare Industry
Islamic Finance
Mergers & Acquisitions
Pharma/Biotech/Med Devices
Overview| People| Matters| Clients| News & Insights

A Global Practice

King & Spalding has one of the world's leading private equity and investment funds practices.  Our partners have been helping large cap, middle market and small cap private equity clients since the mid-1980s.

Global coverage.  We advise private equity clients, including buy-out funds, real estate funds, sovereign wealth funds, venture capital funds and other alternative investment vehicles and other private equity investors doing business in the North American, Latin American, European, Middle Eastern, Russian and Asian markets.  Our lawyers have played a leading role in hundreds of private equity transactions, for both public and private companies, ranging in size from less than $50 million to more than $25 billion.


  • King & Spalding is regularly ranked highly among law firms most involved in the investment, mergers and acquisitions and financing transactions that are integral to private equity investment and exit strategies.

  • In-depth energy law experience.  More than 120 of our lawyers advise energy clients from our offices in Houston, London, Moscow, New York, Singapore, Tokyo, the Middle East, Washington, D.C., Austin and San Francisco.  Our lawyers have extensive transactional and regulatory experience in the domestic and international oil and gas, LNG, petrochemical, electric and nuclear power, renewable and alternative energy and mining and natural resource markets.

  • Unique healthcare and life science law experience.  Our team of healthcare lawyers, scientists and consultants representing U.S. healthcare companies involved in the delivery of healthcare and payment for healthcare services, and private equity investors therein, is one of the largest in the United States.  We also have one of the broadest and deepest benches of lawyers and other professionals specializing in the representation of pharmaceutical, biotechnology and medical technology companies.

  • Presence in the Middle East.  Our team based in Dubai and Riyadh advises on investment transactions across the Persian Gulf countries, North Africa, the Levant and into India and southeast Asia.  Many of our lawyers are native Arabic speakers, and all are familiar with the special requirements of doing business in these regions.  We have one of the world's leading Islamic finance practices.

  • Significant real estate law experience.  We have extensive experience advising managers and sponsors of private real estate investment funds.  We represent numerous real estate investment advisors in connection with real estate transactions, fund formation and management issues, as well as a broad range of domestic and international real estate tax and regulatory matters.


  • Assistance throughout the entire investment cycle.  We assist clients in connection with their control and minority investments, including initial acquisitions, divestitures, add-on acquisitions, financings and various exit transactions, including dispositions, initial public offerings and complex recapitalizations.

  • Comprehensive firm experience.  We provide coordinated teams with comprehensive experience in the areas of mergers and acquisitions; compensation and benefits; tax; senior and high-yield debt finance; corporate finance; Islamic finance; real estate; intellectual property; international trade; environmental; antitrust; and government relations to assist clients with all phases of their investments.

  • Fund Formation and Management.  We have extensive experience in the organization of private investment funds and fund management companies.  We regularly represent sponsors and investment managers, funds of funds, sovereign wealth funds, lead investors, co-investors, placement agents and other advisors.  We also assist fund manager clients in other areas, including internal partnership arrangements, corporate governance, tax planning and regulatory compliance.

  • Advising management teams. We have extensive experience in separately advising portfolio company management teams on their participation in buyouts and other private equity investments by funds. Our interdisciplinary team of executive compensation and tax lawyers help portfolio company managers achieve their equity incentive and compensation objectives over the life of a fund's investment in the managers' employer.


King & Spalding is regularly ranked highly among law firms most involved in the investment, mergers and acquisitions and financing transactions that are integral to private equity investment and exit strategies.  The firm’s key rankings include:

  • King & Spalding is consistently ranked in The Private Equity Analyst as one of the most active law firms in the U.S. representing general partners or limited partners in connection with private equity or venture capital funds.

  • King & Spalding was one of the top 15 law firms in the world advising on private equity transactions in the first half of 2014, according to Bloomberg league tables. The firm ranked 14th by volume among global private equity legal advisors and was credited for its role as counsel in 13 announced deals worth $14.5 billion.

  • MENA Fund Manager named King & Spalding as the Best Advisory Firm for Fund Structuring at its annual Fund Services Awards in 2016.

  • Chambers Global 2015 ranked King & Spalding Band 1 for Investment Funds in the Middle East.

  • Chambers USA includes King & Spalding in top rankings for Corporate/M&A and Venture Capital Investments.

  • “Respected for its work across a range of practice areas including life sciences, technology and energy.”  Chambers USA 2015

  • Our M&A practice is consistently ranked in the top 20 in the U.S.-based on deal size and number of transactions.

  • Our Middle East/Islamic Finance practice is one of the leading such practices in the world.
Raymond E Baltz Jr. (Ray) 
T: +1 404 572 4715 ATLANTA
Richard M Bange III (Rick) 
T: +1 704 503 2554  CHARLOTTE
T: +1 212 556 2376  NEW YORK
Laura I Bushnell 
T: +1 650 422 6713 SILICON VALLEY
William F Charnley 
T: +44 20 7551 7534 LONDON
Kenneth S Culotta (Ken) 
T: +1 713 276 7374 HOUSTON
Mark Davies 
T: +81 3 4510 5604 TOKYO
Mario Leissner 
T: +49 69 257 811 001 FRANKFURT
John D Wilson 
T: +1 212 556 2277 NEW YORK